California Public Employees Retirement System’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-27,500
Closed -$798K 1578
2021
Q1
$798K Sell
27,500
-2,529
-8% -$76.6K ﹤0.01% 2646
2020
Q4
$775K Sell
30,029
-1,448
-5% -$40.3K ﹤0.01% 2652
2020
Q3
$969K Buy
31,477
+6,760
+27% +$236K ﹤0.01% 2303
2020
Q2
$616K Buy
+24,717
New +$565K ﹤0.01% 2558

Other funds holding AKRO

California Public Employees Retirement System's AKRO Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Akero Therapeutics (AKRO) in Q2 2021, closing a stake of 27,500 shares — an estimated $798K sold.

California Public Employees Retirement System first reported a position in AKRO in Q2 2020 and held it in 4 quarters. The position peaked at $969K in Q3 2020. 97 funds tracked by Wall St. Rank hold AKRO as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Akero Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 27,500 Akero Therapeutics shares in Q2 2021, an estimated $798K.
  • California Public Employees Retirement System first reported a position in Akero Therapeutics in Q2 2020 and held it in 4 quarters.
  • California Public Employees Retirement System's Akero Therapeutics position peaked at $969K in Q3 2020.
  • 97 funds tracked by Wall St. Rank held Akero Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.